To assess the possible association of antidiabetic therapy and levels of Tr1 and CD4+IL10+ cells, we performed an extensive correlation analysis with the different clinical and laboratory parameters of the second cohort of patients (mild T2DM). Here, CD4 is linked to type 2 diabetes mellitus.